Drug Shortage Report for TEVA-VORICONAZOLE
| Report ID | 162309 |
| Drug Identification Number | 02396866 |
| Brand name | TEVA-VORICONAZOLE |
| Common or Proper name | VORICONAZOLE 50MG TAB |
| Company Name | TEVA CANADA LIMITED |
| Market Status | MARKETED |
| Active Ingredient(s) | VORICONAZOLE |
| Strength(s) | 50MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL ORAL |
|
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
| Additional packaging sizes | 30 |
| ATC code | J02AC |
| ATC description | ANTIMYCOTICS FOR SYSTEMIC USE |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-01-10 |
| Estimated end date | 2023-01-10 |
| Actual end date | 2023-04-27 |
| Shortage status | Resolved |
| Updated date | 2023-04-28 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2022-06-09 | English | Compare |